Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease
Human Molecular Genetics · 22.05.2024 · 33 (R1) · R3-R11
DOI: 10.1093/hmg/ddae059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Molecular Genetics, online erschienen am 23.05.2024. Verfasst von Stephen P Burr und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0…. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondrial Diseases, Mutation, Organ Specificity. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Collaborative, Wellcome Trust, Medical Research Council Mitochondrial Biology Unit.
Abstract (Originalsprache)
Mutations of mitochondrial (mt)DNA are a major cause of morbidity and mortality in humans, accounting for approximately two thirds of diagnosed mitochondrial disease. However, despite significant advances in technology since the discovery of the first disease-causing mtDNA mutations in 1988, the comprehensive diagnosis and treatment of mtDNA disease remains challenging. This is partly due to the highly variable clinical presentation linked to tissue-specific vulnerability that determines which organs are affected. Organ involvement can vary between different mtDNA mutations, and also between patients carrying the same disease-causing variant. The clinical features frequently overlap with other non-mitochondrial diseases, both rare and common, adding to the diagnostic challenge. Building on previous findings, recent technological advances have cast further light on the mechanisms which underpin the organ vulnerability in mtDNA diseases, but our understanding is far from complete. In this review we explore the origins, current knowledge, and future directions of research in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, United Kingdom.
- Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, United Kingdom.
ORCID-Profile: Patrick F Chinnery
Förderung
- Wellcome Collaborative
- Wellcome Trust
- Medical Research Council Mitochondrial Biology Unit
- Biological and Biotechnology Research Council
- NIHR Cambridge Biomedical Research Centre
- Wellcome Discovery
- Medical Research Council
Zitieren
APA
Burr, S. P., & Chinnery, P. F. (2024). Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease. Human Molecular Genetics, 33(R1), R3-R11. https://doi.org/10.1093/hmg/ddae059
Vancouver
Burr SP, Chinnery PF. Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease. Human Molecular Genetics. 2024;33(R1):R3-R11. doi:10.1093/hmg/ddae059
BibTeX
@article{Burr2024,
author = {Burr, Stephen P and Chinnery, Patrick F},
title = {Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease},
journal = {Human Molecular Genetics},
year = {2024},
volume = {33},
number = {R1},
pages = {R3--R11},
doi = {10.1093/hmg/ddae059}
}
EUVIMED